Centogene CNTG Stock
Centogene Price Chart
Centogene CNTG Financial and Trading Overview
| Centogene stock price | 0.33 USD |
| Previous Close | 0.82 USD |
| Open | 0.82 USD |
| Bid | 0 USD x 2200 |
| Ask | 0 USD x 1300 |
| Day's Range | 0.78 - 0.82 USD |
| 52 Week Range | 0.61 - 2.83 USD |
| Volume | 19.53K USD |
| Avg. Volume | 974.18K USD |
| Market Cap | 22.72M USD |
| Beta (5Y Monthly) | -0.919888 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 1.51 USD |
CNTG Valuation Measures
| Enterprise Value | 46.89M USD |
| Trailing P/E | N/A |
| Forward P/E | -0.7554128 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.478638 |
| Price/Book (mrq) | 3.0609667 |
| Enterprise Value/Revenue | 0.988 |
| Enterprise Value/EBITDA | -1.509 |
Trading Information
Centogene Stock Price History
| Beta (5Y Monthly) | -0.919888 |
| 52-Week Change | -64.37% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 2.83 USD |
| 52 Week Low | 0.61 USD |
| 50-Day Moving Average | 0.81 USD |
| 200-Day Moving Average | 0.97 USD |
CNTG Share Statistics
| Avg. Volume (3 month) | 974.18K USD |
| Avg. Daily Volume (10-Days) | 34.41K USD |
| Shares Outstanding | 27.6M |
| Float | 7.99M |
| Short Ratio | 0.55 |
| % Held by Insiders | 20.83% |
| % Held by Institutions | 65.63% |
| Shares Short | 43.53K |
| Short % of Float | 0.36% |
| Short % of Shares Outstanding | 0.16% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -67.072% |
| Operating Margin (ttm) | -75.67% |
| Gross Margin | 41.95% |
| EBITDA Margin | -65.46% |
Management Effectiveness
| Return on Assets (ttm) | -24.41% |
| Return on Equity (ttm) | -223.27% |
Income Statement
| Revenue (ttm) | 47.47M USD |
| Revenue Per Share (ttm) | 1.77 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -31077000 USD |
| Net Income Avi to Common (ttm) | -38703000 USD |
| Diluted EPS (ttm) | -1.63 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 35.95M USD |
| Total Cash Per Share (mrq) | 1.3 USD |
| Total Debt (mrq) | 60.12M USD |
| Total Debt/Equity (mrq) | 811.25 USD |
| Current Ratio (mrq) | 2.426 |
| Book Value Per Share (mrq) | 0.269 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -26488000 USD |
| Levered Free Cash Flow (ttm) | -21584250 USD |
Profile of Centogene
| Country | United States |
| State | N/A |
| City | Rostock |
| Address | Am Strande 7 |
| ZIP | 18055 |
| Phone | 49 381 80113 500 |
| Website | https://www.centogene.com |
| Industry | Diagnostics & Research |
| Sector(s) | Healthcare |
| Full Time Employees | 444 |
Centogene N.V., together with its subsidiaries, engages in the research and development of products for human genetics in Europe, the Middle East, North America, Latin America, and the Asia Pacific. It provides data-driven answers to patients, physicians, and pharmaceutical companies for rare and neurodegenerative diseases. It operates through two segments: Pharmaceutical and Diagnostics. The company provides target and drug screening, clinical development, market access and expansion, as well as CENTOGENE Biodatabank licenses and insight report services. In addition, it offers various services, including early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring; and genetic sequencing and diagnostics services to physicians, laboratories, or hospitals directly or through distributors. Centogene N.V. was founded in 2006 and is headquartered in Rostock, Germany.
Q&A For Centogene Stock
What is a current CNTG stock price?
Centogene CNTG stock price today per share is 0.33 USD.
How to purchase Centogene stock?
You can buy CNTG shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Centogene?
The stock symbol or ticker of Centogene is CNTG.
Which industry does the Centogene company belong to?
The Centogene industry is Diagnostics & Research.
How many shares does Centogene have in circulation?
The max supply of Centogene shares is 29M.
What is Centogene Price to Earnings Ratio (PE Ratio)?
Centogene PE Ratio is 0.00000000 now.
What was Centogene earnings per share over the trailing 12 months (TTM)?
Centogene EPS is 0 USD over the trailing 12 months.
Which sector does the Centogene company belong to?
The Centogene sector is Healthcare.
Centogene CNTG included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 19634.52 USD — |
-0.24
|
6.4B USD — | 19575.21 USD — | 19969.17 USD — | — - | 6.4B USD — |
| NASDAQ Global Market Composite NQGM | 2345.17 USD — |
-1.28
|
— — | 2341.77 USD — | 2397.99 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 1022.81 USD — |
-0.5
|
— — | 1021.97 USD — | 1039.72 USD — | — - | — — |
- {{ link.label }} {{link}}